We performed technical optimization followed by a pilot clinical study of quiescent‐interval single‐shot MR angiography for peripheral vascular disease. Quiescent‐interval single‐shot MR angiography acquires data using a modified electrocardiographic (ECG)‐triggered, fat suppressed, two‐dimensional, balanced steady‐state, free precession pulse sequence incorporating slice‐selective saturation and a quiescent interval for maximal enhancement of inflowing blood. Following optimization at 1.5 T, a pilot study was performed in patients with peripheral vascular disease, using contrast‐enhanced MR angiography as the reference standard. The optimized sequence used a quiescent interval of 228 ms, α/2 catalyzation of the steady‐state magnetization, and center‐to‐out partial Fourier acquisition with parallel acceleration factor of 2. Spatial resolution was 2‐3mm along the slice direction and 0.7‐1mm in‐plane before interpolation. Excluding stented arterial segments, the sensitivity, specificity, and positive and negative predictive values of quiescent‐interval single‐shot MR angiography for arterial narrowing greater than 50% or occlusion were 92.2%, 94.9%, 83.9%, and 97.7%, respectively. Quiescent‐interval single‐shot MR angiography provided robust depiction of normal peripheral arterial anatomy and peripheral vascular disease in less than 10 min, without the need to tailor the technique for individual patients. Moreover, the technique provides consistent image quality in the pelvic region despite the presence of respiratory and bowel motion. Magn Reson Med 63:951–958, 2010.
19 December 2018 in Journal of Magnetic Resonance Imaging
Quiescent-interval single-shot nonenhanced MR angiography offers an alternative to currently used imaging tests for symptomatic chronic lower limb ischemia, for which the administration of iodinate... PurposeTo assess the diagnostic performance of quiescent-interval single-shot (QISS) magnetic resonance (MR) angiography, a nonenhanced two-dimensional electrocardiographically gated single-shot ba...
5 April 2013 in Journal of Magnetic Resonance Imaging
Purpose: To implement, optimize, and test fast interrupted steady‐state (FISS) for natively fat‐suppressed free‐running 5D whole‐heart MRI at 1.5 tesla (T) and 3T.Methods: FISS was implemented for fully self‐gated free‐running cardiac‐ and respiratory‐motion‐resolved radial imaging of the heart at 1.5T and 3T. Numerical simulations and phantom scans were performed to compare fat suppression characteristics and to determine parameter ranges (number of readouts [NR] per FISS module and TR) for effective fat suppression. Subsequently, free‐running FISS data were collected in 10 healthy volunteers and images were reconstructed with compressed sensing. All acquisitions were compared with a continuous balanced steady‐state free precession version of the same sequence, and both fat suppression and scan times were analyzed.Results: Simulations demonstrate a variable width and location of suppression bands in FISS that were dependent on TR and NR. For a fat suppression bandwidth of 100 Hz and NR ≤ 8, simulations demonstrated that a TR between 2.2 ms and 3.0 ms is required at 1.5T, whereas a range of 3.0 ms to 3.5 ms applies at 3T. Fat signal increases with NR. These findings were corroborated in phantom experiments. In volunteers, fat SNR was significantly decreased using FISS compared with balanced steady‐state free precession (P < 0.05) at both field strengths. After protocol optimization, high‐resolution (1.1 mm3) 5D whole‐heart free‐running FISS can be performed with effective fat suppression in under 8 min at 1.5T and 3T at a modest scan time increase compared to balanced steady‐state free precession.Conclusion: An optimal FISS parameter range was determined enabling natively fat‐suppressed 5D whole‐heart free‐running MRI with a single continuous scan at 1.5T and 3T, demonstrating potential for cardiac imaging and noncontrast angiography.
10 March 2016 in American Journal of Neuroradiology
BACKGROUND AND PURPOSE: Quantitative susceptibility mapping has been shown to assess iron content in cerebral cavernous malformations. In this study, our aim was to correlate lesional iron deposition assessed by quantitative susceptibility mapping with clinical and disease features in patients with cerebral cavernous malformations. MATERIALS AND METHODS: Patients underwent routine clinical scans in addition to quantitative susceptibility mapping on 3T systems. Data from 105 patients met the inclusion criteria. Cerebral cavernous malformation lesions identified on susceptibility maps were cross-verified by T2-weighted images and differentiated on the basis of prior overt hemorrhage. Mean susceptibility per cerebral cavernous malformation lesion (χ̄lesion) was measured to correlate with lesion volume, age at scanning, and hemorrhagic history. Temporal rates of change in χ̄lesion were evaluated in 33 patients. RESULTS: Average χ̄lesion per patient was positively correlated with patient age at scanning (P < .05, 4.1% change with each decade of life). Cerebral cavernous malformation lesions with prior overt hemorrhages exhibited higher χ̄lesion than those without (P < .05). Changes in χ̄lesion during 3- to 15-month follow-up were small in patients without new hemorrhage between the 2 scans (bias = −0.0003; 95% CI, −0.06–0.06). CONCLUSIONS: The study revealed a positive correlation between mean quantitative susceptibility mapping signal and patient age in cerebral cavernous malformation lesions, higher mean quantitative susceptibility mapping signal in hemorrhagic lesions, and minimum longitudinal quantitative susceptibility mapping signal change in clinically stable lesions. Quantitative susceptibility mapping has the potential to be a novel imaging biomarker supplementing conventional imaging in cerebral cavernous malformations. The clinical significance of such measures merits further study.